Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer (Q39790504)

14 September 2017

title

Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer (English)

1 reference

14 September 2017

1 reference

Kyung Sook Park

1

1 reference

14 September 2017

Seon Jeong Kim

series ordinal

2

1 reference

14 September 2017

Kyung Ho Kim

series ordinal

3

1 reference

14 September 2017

Jin Cheon Kim

series ordinal

4

1 reference

14 September 2017

publication date

1 February 2011

1 reference

Journal of Gastroenterology and Hepatology

14 September 2017

published in

1 reference

14 September 2017

volume

26

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

391-397

1 reference

Mapping proteolytic cancer cell-extracellular matrix interfaces

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

The regulation of matrix metalloproteinases and their inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Role of matrix metalloproteinases (MMPs) in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

TIMP-2: an endogenous inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Matrix metalloproteinases in colorectal cancer: is it worth talking about?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

Matrix metalloproteinase-9-1562C>T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06504.X

10.1111/J.1440-1746.2010.06504.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference